Evidence map›Paper›PMID 21149447›Full record

ArticleThe Journal of biological chemistry2011

Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis.

Sonali Joshi, Bhumika Sharma, Surinder Kaur, Beata Majchrzak, Takeshi Ueda, Rikiro Fukunaga, Amit K Verma, Eleanor N Fish, Leonidas C Platanias

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Mnk kinase pathway: Cellular functions and biological outcomes.World journal of biological chemistry · 2014
    Review
  15. Regulation of interferon-dependent mRNA translation of target genes.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2014
    Review
  16. Article
  17. Article
  18. The oncogene eIF4E: using biochemical insights to target cancer.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2013
    Review
  19. The schlafen family of proteins and their regulation by interferons.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Sonali JoshiRobert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
Bhumika Sharma
Surinder Kaur
Beata Majchrzak
Takeshi Ueda
Rikiro Fukunaga
Amit K Verma
Eleanor N Fish
Leonidas C Platanias
Jesse Brown VA Medical Center · USAlbert Einstein College of Medicine · USHiroshima University · JPKyoto University · JPUniversity Health Network · CAUniversity of Toronto · CA

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Signal Transduction of Type I Interferons in Malignant CellsR01CA077816 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PLATANIAS, LEONIDAS C. · 1998 to 2024
$6.6M
Targeting Novel Protein Complexes for the Treatment of Acute Myeloid LeukemiaR01CA121192 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PLATANIAS, LEONIDAS C. · 2006 to 2023
$4.1M
Map Kinase Pathways and Anemia in the ElderlyR01AG029138 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PLATANIAS, LEONIDAS C. · 2007 to 2010
$804k
NCI NIH HHS CA121192NCI NIH HHS CA77816NCI NIH HHS P30 CA060553NCI NIH HHS R01 CA077816NCI NIH HHS R01 CA121192NHLBI NIH HHS HL08294NIA NIH HHS R01 AG029138
6 · The paper itself

Abstract

IFNγ exhibits potent antitumor effects and plays important roles in the innate immunity against cancer. However, the mechanisms accounting for the antiproliferative effects of IFNγ still remain to be elucidated. We examined the role of Mnk1 (MAPK-interacting protein kinase 1) in IFNγ signaling. Our data demonstrate that IFNγ treatment of sensitive cells results in engagement of Mnk1, activation of its kinase domain, and downstream phosphorylation of the cap-binding protein eIF4E on Ser-209. Such engagement of Mnk1 plays an important role in IFNγ-induced IRF-1 (IFN regulatory factor 1) gene mRNA translation/protein expression and is essential for generation of antiproliferative responses. In studies aimed to determine the role of Mnk1 in the induction of the suppressive effects of IFNs on primitive hematopoietic progenitors, we found that siRNA-mediated Mnk1/2 knockdown results in partial reversal of the suppressive effects of IFNγ on human CD34+-derived myeloid (CFU-GM) and erythroid (BFU-E) progenitors. These findings establish a key role for the Mnk/eIF4E pathway in the regulatory effects of IFNγ on normal hematopoiesis and identify Mnk kinases as important elements in the control of IFNγ-inducible ISG mRNA translation.

Indexed as

AnimalsCell Line, TransformedEnzyme ActivationErythroid Precursor CellsEukaryotic Initiation Factor-4EGene Knockdown TechniquesHematopoiesisHumansInterferon-gammaInterferon Regulatory Factor-1Intracellular Signaling Peptides and ProteinsMiceMice, KnockoutMyeloid Progenitor CellsPhosphorylationProtein Serine-Threonine KinasesEukaryotic Initiation Factor-4EInterferon-gammaInterferon Regulatory Factor-1Intracellular Signaling Peptides and ProteinsIRF1 protein, humanIrf1 protein, mouseMKNK1 protein, humanMknk1 protein, mouseMKNK2 protein, humanMknk2 protein, mouseProtein Serine-Threonine Kinases

Identifiers

PMID21149447
PMCPMC3057839
OpenAlexW2015514843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.